Clinical Research

Meta-Analysis

A systematic review and meta-analysis found that adenosine triphosphate (ATP) supplementation led to significant improvements in maximal strength compared to a placebo, particularly in resistance-trained men at doses of 400 mg/day. Moreover, daily intake of 400 mg of ATP for up to 12 weeks was deemed safe for healthy individuals.

The Effect of Oral Adenosine Triphosphate (ATP) Supplementation on Anaerobic Exercise in Healthy Resistance-Trained Individuals: A Systematic Review and Meta-Analysis 

Acute Effects on Work Capacity

One serving of ATP diminishes exercise-induced fatigue, allowing users to sustain performance for extended durations.

The aim of the research was to examine how a single dose of disodium Adenosine Triphosphate (ATP) affects muscular performance in trained adults. In this acute, crossover, randomized, double-blind, placebo-controlled study, 18 trained males were enlisted to perform a series of strength tests following supplementation with either 400 mg of PEAK ATP® or a placebo. While acute supplementation didn’t yield notable enhancements in muscle strength indicators, it did demonstrate a reduction in fatigue levels over the course of the exercise, resulting in improved performance endurance.

Acute Effect of Oral Adenosine Triphosphate (ATP) Supplementation on Muscular Performance in Trained Adults

Cognitive Function

PEAK ATP® improves cognitive function following exercise.

The study examined the acute effect of PEAK ATP® vs. placebo on cognitive function, reaction time, multiple object tracking and mood in healthy men and women before and after a fatiguing exercise protocol.  

In this placebo-controlled crossover study 20 adults that were healthy, recreationally active individuals between ages 18-40 participated in the 14-day study.  Subjects were given PEAK ATP® or placebo to ingest before performing an all-out three-minute sprint test on a cycle erometer (3MT).  

Researchers measured visuomotor reaction time, multiple object tracking speed, mood and cognition before and after participants’ high-intensity exercise bouts. Researchers found that subjects supplementing with PEAK ATP® maintained proactive reaction time and improved reactive reaction time following a high-intensity sprint exercise.  The study also showed that PEAK ATP® supplementation was able to decrease the number of errors during a reactive visuomotor task.  It also suggested that ATP may mitigate exercise induced cognitive dysfunction.   

Evaluating the effects of PeakATP® supplementation on visuomotor reaction time and cognitive function following high-intensity sprint exercise

Energy Expenditure

A single dose of PEAK ATP® improved lower-body resistance training performance and energy expenditure.

The goal of this study was to examine the acute effect of PEAK ATP® supplementation on performance and physiological responses during resistance exercise in recreationally trained men.  In a randomized, double-blind study, 11 trained male subjects were given PEAK ATP® (400 mg) or a placebo supplement.  Each subject completed 3 experimental trials where they completed sets of half-squats until reaching momentary muscular failure (fatigue).  An acute dose of PEAK ATP® supplementation improved the number of repetitions performed as well as oxygen consumption and energy expenditure during exercise. This study suggests that supplementing with PEAK ATP® prior to a fatiguing, high volume lower body training session can enhance lifting performance.

A Single Dose of Oral ATP Supplementation Improves Performance and Physiological Response During Lower Body Resistance Exercise in Recreational Resistance-Trained Males

HIIT Adaptations

PEAK ATP® increased participants’ post-exercise ATP levels, muscle excitability, and sprint performance following a repeated sprint bout.

In a double-blind, placebo-controlled, randomized design study, 42 healthy, trained men were given either 400 mg of PEAK ATP® or a placebo for 2 weeks.  A repeated sprint exercise test was performed before and after the supplementation period.  During the sprint bout, muscle activation and excitability, and power were measured. Oral PEAK ATP® supplementation prevented exercise-induced declines in ATP and its metabolites. PEAK ATP® supplementation also enhanced peak power and muscular excitability. This study suggests PEAK ATP® supplementation would be beneficial for sports requiring repeated high-intensity sprinting bouts.

Oral Adenosine-5′-triphosphate (ATP) Administration Increases Postexercise ATP Levels, Muscle Excitability, and Athletic Performance Following a Repeated Sprint Bout

Blood Flow

PEAK ATP® significantly increased vasodilation and blood flow after exercise.

Twelve college-aged, resistance-trained male subjects took 400 mg of PEAK ATP® daily, either before breakfast or 30 minutes prior to exercise. Vasodilation and blood flow were measured in the brachial artery by ultrasound before exercise and at 0, 3, and 6 minutes after performing acute arm exercise (30 sets of 20 contractions at 50% 1-RM). This study demonstrates the ability of PEAK ATP® to improve muscle blood flow during and/or after exercise, which may enhance the delivery of oxygen and nutrients to the muscle as well as waste removal from the muscle

Oral adenosine-5′-triphosphate (ATP) administration increases blood flow following exercise in animals and humans

Power and Strength

PEAK ATP® supplementation effectively doubles muscular performance gains in response to intense training. 
A double-blind, placebo-controlled study investigated the effect of PEAK ATP® on strength, power, lean body mass, and markers of muscular damage. Twenty-one resistance-trained men took either 400 mg of PEAK ATP® or a placebo daily for 12 weeks. PEAK ATP® supplementation:
  • Increased strength (147% increase over placebo)
  • Increased power (30% increase over placebo)
  • Increased lean body mass (100% increase over placebo)
  • Increased muscle thickness (96% increase over placebo)
Effects of oral adenosine-5′-triphosphate supplementation on athletic performance, skeletal muscle hypertrophy and recovery in resistance-trained men

Force Output and Fatigue

PEAK ATP® maintained force output and tended to reduce muscle fatigue during exhaustive exercise.

A double-blind, placebo-controlled, human crossover study assessed the muscle performance-enhancing effects of 400 mg of PEAK ATP® (200 mg twice daily) on healthy, active adults. Sixteen male and female participants were randomized to receive either PEAK ATP® or placebo for 15 days. Before and after each supplementation period, each participant completed a muscle strength and fatigue test consisting of three sets of 50 maximal knee extensions. After a one-week washout period, the groups were switched, so that those who had been taking placebo now took PEAK ATP® and vice versa. PEAK ATP® improved participants’ ability to maintain force output during an exhaustive exercise bout and tended to reduce muscle fatigue.

Adenosine-5′-triphosphate (ATP) supplementation improves low peak muscle torque and torque fatigue during repeated high intensity exercise sets